Takara Holdings Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial ReportiCD ResearchFebruary 6, 2012 29 Pages - SKU: ICDR6792900 |
| Synopsis ICD Research's Takara Holdings Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries. Summary ICD Research's Takara Holdings Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Takara Holdings Inc.. ICD Research's Takara Holdings Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Takara Holdings Inc. (Takara) is a holding company, which manufactures and markets products for the alcohol, food and bio medical markets. The company offers a wide spectrum of alcoholic beverages and seasonings such as shochu, sake, and light alcohol refreshers, research reagents and scientific instruments and contract research services to its customers. The company through Takara Shuzo Group produces alcoholic beverages and seasonings business; through the Takara Bio Group operates in biomedical business; and through Takara Healthcare Inc., offers health foods. It operates principally in Japan and sells its products in more than 40 countries across Europe, the US, and Asia. Takara is headquartered in Kyoto, Japan. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

